Evidence map›Paper›PMID 32376625›Full record

ArticleJournal of virology2020

Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes.

Gisele Umviligihozo, Kyle D Cobarrubias, Sandali Chandrarathna, Steven W Jin, Nicole Reddy, Helen Byakwaga, Conrad Muzoora, Mwebesa B Bwana, Guinevere Q Lee, Peter W Hunt and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 7 countries.

Gisele UmviligihozoFaculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada.
Kyle D CobarrubiasFaculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada.
Sandali ChandrarathnaFaculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada.
Steven W JinFaculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada.
Nicole ReddyUniversity of KwaZulu-Natal, Durban, South Africa.
Helen ByakwagaMbarara University of Science and Technology, Mbarara, Uganda.
Conrad MuzooraMbarara University of Science and Technology, Mbarara, Uganda.
Mwebesa B BwanaMbarara University of Science and Technology, Mbarara, Uganda.
Guinevere Q LeeBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Peter W HuntUniversity of California, San Francisco, California, USA.
Jeff N MartinUniversity of California, San Francisco, California, USA.
Chanson J BrummeBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
David R BangsbergOregon Health and Science University-Portland State University School of Public Health, Portland, Oregon, USA.
Etienne KaritaRwanda Zambia HIV Research Group-Projet San Francisco, Kigali, Rwanda.
Susan AllenRwanda Zambia HIV Research Group-Projet San Francisco, Kigali, Rwanda.
Eric HunterRwanda Zambia HIV Research Group-Projet San Francisco, Kigali, Rwanda.
Thumbi Ndung'uUniversity of KwaZulu-Natal, Durban, South Africa.
Zabrina L Brumme *Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada.ORCID 0000-0002-8157-1037
Mark A Brockman *Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada mbrockma@sfu.ca.ORCID 0000-0001-6432-1426
Simon Fraser University · CAMbarara University of Science and Technology · UGEmory University · USUniversity of California, San Francisco · USAfrica Health Research Institute · ZAAIDS Vancouver · CAMax Planck Institute for Infection Biology · DEPortland State University · USRwanda Zambia HIV Research Group · RWUniversity of British Columbia · CA

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
Virologic Correlates of Heterosexual TransmissionR01AI051231 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALLEN, TODD M, HUNTER, ERIC · 2002 to 2022
$9.9M
NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI051231NIH HHS P51 OD011132NIMH NIH HHS R01 MH054907Wellcome TrustWellcome Trust 107752/Z/15/Z
6 · The paper itself

Abstract

Downregulation of BST-2/tetherin and CD4 by HIV-1 viral protein U (Vpu) promotes viral egress and allows infected cells to evade host immunity. Little is known however about the natural variability in these Vpu functions among the genetically diverse viral subtypes that contribute to the HIV-1 pandemic. We collected Vpu isolates from 332 treatment-naive individuals living with chronic HIV-1 infection in Uganda, Rwanda, South Africa, and Canada. Together, these Vpu isolates represent four major HIV-1 group M subtypes (A [

Indexed as

Down-RegulationHIV InfectionsAntigens, CDBone Marrow Stromal Antigen 2CD4 AntigensCell Line, TransformedChronic DiseaseGPI-Linked ProteinsHIV-1Human Immunodeficiency Virus ProteinsHumansViral Regulatory and Accessory ProteinsViroporin ProteinsAntigens, CDBone Marrow Stromal Antigen 2BST2 protein, humanCD4 AntigensGPI-Linked ProteinsHuman Immunodeficiency Virus ProteinsViral Regulatory and Accessory ProteinsViroporin Proteinsvpu protein, Human immunodeficiency virus 1CD4DownregulationHIV-1subtypetetherinVpu

Identifiers

PMID32376625
PMCPMC7343213
OpenAlexW3023728879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.